-
Bluebird, Regeneron Team Up To Make Cell Therapies For Cancer
Xconomy | Regeneron and Bluebird have struck a wide-ranging deal to broaden the reach of their respective cancer immunotherapy work, inking a deal to develop multiple cell therapies together.
Aug 6, 2018
-
Denial And Data Science: How You Must Change Your Thinking To Work In A Data Driven Environment
Bio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Samantha G. Zeitlin about the optimal environment to grow data science, the skillsets necessary in the data science industry, and more.
Aug 3, 2018
-
Precision Communication For Precision Medicine: How NIH’s All Of Us Is Tackling Patient Recruitment
Clinical Informatics News | In May, the National Institutes of Health launched national open enrollment for their All of Us Research Program. Now, the precision medicine is looking to make a difference in their approach to outreach.
Aug 2, 2018
-
Quartzy, ACD/Labs, Eli Lilly, And More: News From July 2018
Bio-IT World | July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Quartzy, ACD/Labs, Eli Lilly, and more.
Jul 30, 2018
-
What AI Professionals Worry About As AI Clears The Hype Curve
Bio-IT World | When it comes to a hype curve, AI is coasting along it. This spring, Bio-IT World surveyed 124 professionals from pharma, biotech, academia, and more about the biggest opportunities and concerns associated with AI.
Jul 26, 2018
-
23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs
Forbes | GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe. The collaboration will last four years.
Jul 25, 2018
-
Looking Forward: How Data Science Shapes Future Work
Bio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Gaurav Kaushik, Associate Director, Data Products & Strategy at Foundation Medicine for his definition of “data science.”
Jul 25, 2018
-
Illumina Releases Open Source AI Software
Bio-IT World Brief | Illumina announced the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals.
Jul 24, 2018
-
Eight New Mouse Models For Alzheimer’s Disease Available To Researchers
Bio-IT World Brief | The MODEL-AD Center, an ambitious project to develop and distribute precise mouse models of late-onset Alzheimer’s disease (AD), has released eight new models carrying genetic mutations found in patients.
Jul 23, 2018
-
Human Longevity Blasts Craig Venter, Claiming He Was Fired, Then Stole Trade Secrets — Poaching Staffers For Rival Operation
Endpoints News | On Friday, Human Longevity filed suit against ex-CEO and executive chairman Craig Venter, claiming that Venter had stolen trade secrets, recruited staffers, and planned to set up a rival organization.
Jul 23, 2018
-
VA, IBM Extend Watson For Genomics Partnership
Bio-IT World Brief | Today the US Department of Veterans Affairs and IBM Watson Health announced the extension of a public-private partnership to apply artificial intelligence to help interpret cancer data in the treatment of Veteran patients.
Jul 19, 2018
-
Quartzy Opens Second Distribution Warehouse, Expanding Options To Serve Software Customers
Bio-IT World | Quartzy, a free online laboratory supply management and ordering platform, has expanded distribution operations with a new 40,000 square foot warehouse in Hayward, California, and grown its lab supply portfolio to over three million SKUs.
Jul 19, 2018
-
Tetraphase Selects SHYFT To Support Data And Analytics For Commercial Launch Readiness
Bio-IT World Brief | SHYFT Analytics announced Tetraphase has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria.
Jul 18, 2018
-
AWS Unveils New HPC Instances With Fast Cores
TOP500 | Amazon Web Services has announced a new set of instances designed for applications that can benefit from high core performance.
Jul 18, 2018
-
Government Insurers Balk At Paying For CAR-T Cancer Drug
NPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.
Jul 17, 2018
-
Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements
GEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.
Jul 16, 2018
-
Leaders In Biobanking Congress: Unlocking The Potential
Bio-IT World | This year, the 10th annual Leaders in Biobanking Congress will take place in Cleveland, Ohio from October 14-16. Biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners will converge to discuss the various aims for biospecimen collections, from basic research to clinical trials.
Jul 16, 2018
-
Superbugs Win Another Round As Big Pharma Leaves Antibiotics
Bloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.
Jul 13, 2018
-
I'm Adopted, Should I Have DNA Testing?
Forbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.
Jul 11, 2018
-
BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio
Bio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
Jul 9, 2018